Loading organizations...
Key people at Fosun Health Capital.
Fosun Health Capital is a Shanghai, China-based private equity firm that invests in early venture opportunities across the global healthcare and health technology sectors. Operating as a specialized investment arm of the broader Fosun Group, the firm deploys private capital into pharmaceuticals, medical devices, diagnostics, and healthcare services. While specific assets under management remain undisclosed, the organization operates with a core investment team that includes four primary decision makers managing the active portfolio. The firm strategically aligns its investment approach with the diversified health ecosystem overseen by Fosun Group executives Chen Qiyu, Xu Xiaoliang, and Wang Qunbin. Fosun Health Capital was established in 2020 as a dedicated healthcare extension of the parent conglomerate, which was originally founded in 1992 by Fudan University graduates Guo Guangchang, Liang Xinjun, Wang Qunbin, Fan Wei, and Tan Jian.
Fosun Health Capital has 2 tracked investments across 2 companies. The latest tracked deal is $14.0M Seed in Atantares in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2023 | Atantares | $14.0M Seed | ALI Health, Asia Green Fund | Qiming Venture Partners, Jiachen Capital, Neux Capital |
| Aug 22, 2022 | Porton Advanced Solutions | $80.0M Series B | China Merchants Capital, Merchant Health | CS Capital, Gortune Investment, HM Capital, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, Sdictk |
Key people at Fosun Health Capital.